Parkinson’s disease is the second most common incurable neurodegenerative disorder after Alzheimer’s disease.
It is characterised by the accumulation of protein deposits in dopaminergic neurons (in charge of producing dopamine) in the form of amyloid fibres. These aggregates are formed mainly by the alpha-synuclein protein and in a very complex manner, which makes it complicated to identify molecules which could prevent or revert the process and the neurodegeneration associated with it.
A scientific collaboration led by researchers at the Institute of Biotechnology and Biomedicine (IBB) of the Universitat Autònoma de Barcelona has identified a molecule which halts and reverts this neurodegeneration. After analysing over 14,000 molecules, they found the SynuClean-D molecule, which inhibits the aggregation of the alpha-synuclein protein and breaks the already formed amyloid fibres, thus preventing the initiation of the process causing the onset of the neurodegenerative Parkinson’s disease.
Through experiments conducted with the small Caenorhabditis elegans worm, one of the most commonly used animal models in neurodegenerative diseases, researchers were able to verify that by administering it through food, the molecule was capable of notably reducing alpha-synuclein aggregations, preventing the spread of toxic aggregates and therefore avoiding the degeneration of dopaminergic neurons.
“Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative disases such as Parkinson’s in the future”, UAB researcher and coordinator of the study Salvador Ventura points out.
To identify SynuClean-D researchers developed a methodology capable of indentifying the alpha-synuclein aggregation inhibitors among thousands of molecules. Once identified, an in vitro biophysical characterisation was conducted of their inhibiting activity and tests were run to discover their behaviour with human neural cell cultures, before testing it in animal models of the disease (the Caenorhabditis elegans worm). These animals express the alpha-synuclein in the muscle or in dopaminergic neurons. The experiments demonstrated that the administration of the identified inhibitor reduced protein aggregation, improving the mobility of the animal and protecting it from neural degeneration.
The Latest on: Parkinson’s
via Google News
The Latest on: Parkinson’s
- Latest News in Parkinson Disease: Gene Therapy Clinical Trials, FDA Approves Novel DBS System, and Moreon June 18, 2021 at 1:30 pm
An overview of the latest news in Parkinson disease (PD) reported across MJH Life Sciences ™. As reported by NeurologyLive®, Bayer announced updates on their phase 1 and phase 1b clinical trials of ...
- Herbert Parkinson named winner of Risk Reduction Through Design Awardon June 18, 2021 at 1:01 pm
British textile manufacturer Herbert Parkinson has received an award for an innovative tool that helps protect workers from developing musculoskeletal disorders (MSDs). The Risk Reduction Through ...
- Will reduction in tau protein protect against Parkinson's and Lewy body dementias?on June 18, 2021 at 10:45 am
A new study, published in the journal eNeuro, suggests the answer is no. If this is borne out, that result differs from Alzheimer's disease, where reducing endogenous tau levels in brain neurons is ...
- Muhammad Ali’s daughter Rasheda marks ‘bittersweet’ Father’s Day with Parkinson’s auctionon June 18, 2021 at 4:00 am
June marks the five-year anniversary of Muhammad Ali’s death and his daughter Rasheda Ali Walsh has chosen Father’s Day to pick a fight with Parkinson’s disease — the one rival her dad couldn’t whoop.
- What Mr. Rogers Reminded Me After Being Diagnosed With Parkinson’son June 18, 2021 at 2:42 am
As a child, he walked into my living room each day and asked the simple question, “Won’t you be my neighbor?” With his cardigan sweaters, sneakers and simple, quiet ways, he took me and millions of ...
- Photo | Local advocate enjoys Taiko for People with Parkinson’son June 17, 2021 at 11:39 pm
Mary Haynes, who was diagnosed in the 1990s with Parkinson’s Disease – an incurable, progressive neurological condition – will be honored in July for her work on behalf of the local ...
- Pedaling for Parkinson’s: CNY spin class fends off effects of disease (video)on June 17, 2021 at 11:25 am
Wednesday and Friday, a small group meets for a private spin class in the back area of Pacific Health Club. All the cycling students have Parkinson’s disease. They pedal to the beat of classic songs ...
- Mike Tindall Praises 'Brilliant' Wife Zara for Supporting His Dad's Parkinson's Battle: 'She Gets It'on June 17, 2021 at 10:54 am
Zara and Mike Tindall. Mike Tindall is opening up about his "brilliant" wife, Zara Tindall. Mike, 42, who married Queen Elizabeth's granddaughter in July 2011 - just three months ...
- Mike Tindall praises Zara for helping him understand how Parkinson's affects his dadon June 16, 2021 at 5:05 am
Mike Tindall has praised his wife Zara for helping him understand more about Parkinson's disease, following his father's diagnosis. The former England rugby player has been speaking openly about his ...
via Bing News